New Leaf Ventures Inc

OTC: NLVVF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, BCReports USD

#820 of 1,394 Healthcare companies by revenue26th-percentile growth

EA Score

——

FH —DQ —GM —SS 20

v0.1 · 5/100 weight · pillars only

↑ Altman-Z, net margin · ↓ Piotroski F, market scale

Methodology →

Revenue TTM

$1.1M

Rev growth YoY (TTM)

-42.5%

Net income (FY)

-$2.7M

Employees

Market cap

$3.0k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$1.5M2.0M CAD2022

Net income-$2.7M-3.5M CAD2022

Operating income-$3.0M-3.9M CAD2022

Total assets$1.7M2.3M CAD2022

Liabilities$2.7M3.6M CAD2022

Equity-$999.9k-1.4M CAD2022

Revenue trend

FY2018 – FY2022 · USD

FY18

FY19

$1.5M

FY20

$2.0M

FY21

$1.5M

FY22

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

New Leaf Ventures Inc booked $1.5M in FY2022 revenue, contracting 23% year over year — slower than 74% of Healthcare companies we track, at a -177.7% net margin.

Peers · Healthcare

Synovics Pharmaceuticals, Inc.——Acutus Medical, Inc.——INDVR Brands Inc.——Comera Life Sciences Holdings, Inc.——

Key facts

CEORobert Colwell

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, BC

ExchangeOTC: NLVVF

Employees12

IPO date2021-01-08

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.